ELMO1 and leukemia: Further studies using in vivo leukemia models are necessary to assess whether ELMO1 depletion could affect LSC homing and long-term engraftment, and ultimately whether targeting ELMO1 might have therapeutic benefit in the treatment of leukemia patients.